Kadefemin Mycostop 200 mg / 2%, Vaginaltabletten und Creme

7680677360015 CH-67736 G01AF02 09.03.0.

Active substances:

Kadefemin Mycostop 200 mg / 2%, Vaginaltabletten und Creme
Kadefemin Mycostop 200 mg / 2%, Vaginaltabletten und Creme
Kadefemin Mycostop 200 mg / 2%, Vaginaltabletten und Creme
1 / 3
google

Details

Product number
6773601
CPT
-
Packaging group
1
Unit
Kombipackung(en)
Composition
I) Kadefemin Mycostop, Vaginaltabletten: clotrimazolum 200.0 mg, polysorbatum 80, silica colloidalis anhydrica, magnesii stearas, acidum stearicum, natrii hydrogenocarbonas, acidum adipicum, amylum pregelificatum, lactosum monohydricum, pro compresso. II) Kadefemin Mycostop, Creme: clotrimazolum 20.00 mg, alcohol benzylicus 10.00 mg, polysorbatum 60, sorbitani stearas, cetylis palmitas, alcohol cetylicus et stearylicus 100.00 mg, octyldodecanolum, aqua purificata, ad unguentum pro 1 g.

Articles (1)

Kadefemin Mycostop 200 mg / 2%, Vaginaltabletten und Creme
Vaginaltabletten
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/06/2022
Patient information leaflet
Français
21/06/2022
Patient information leaflet
Italien
21/06/2022
Professional SmPC
Allemand
21/06/2022
Professional SmPC
Français
21/06/2022
Professional SmPC
Italien
21/06/2022

Detailed composition

Substance Quantity Type Category
clotrimazolum
20.0 MG Substance Wirkstoff (Principe actif)
clotrimazolum
200.0 MG Substance Wirkstoff (Principe actif)
alcohol benzylicus
10.0 MG Substance HBESI
polysorbatum 80
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
polysorbatum 60
- Substance HNIDK
magnesii stearas
- Substance HNIDK
sorbitani stearas
- Substance HNIDK
acidum stearicum
- Substance HNIDK
cetylis palmitas
- Substance HNIDK
alcohol cetylicus et stearylicus
100.0 MG Substance HBESI
natrii hydrogenocarbonas
- Substance HNIDK
octyldodecanolum
- Substance HNIDK
acidum adipicum
- Substance HNIDK
aqua purificata
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
lactosum monohydricum
- Substance HNIDK

Authorization holder

Max Zeller Söhne AG

8590 Romanshorn

Authorization information

Swissmedic authorization number
67736
Drug name
Kadefemin Mycostop, Vaginaltabletten und Creme
Galenic form
KOMB
ATC Code
G01AF02
Authorization status
Z
Dispensation category
D
First authorization
20/07/2021
Authorization expiration date
31/12/9999
IT number
09.03.0.
Domain
Human medicine
Field of application
Durch Clotrimazol-empfindliche Erreger verursachte vulvovaginale Infektionen

Packaging details

Description (FR)
KADEFEMINE Mycostop emb combi 3 cpr vag+20 g crème
Description (DE)
KADEFEMIN Mycostop Kombipack 3 Vag Tabl+20 g Creme
Market launch
20/07/2021
Market withdrawal
01/09/2025
Narcotic (BTM)
No
Buy us a coffee Explore the data